| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Serological analysis of serum samples from humans exposed to avian H7 influenza viruses in Italy between 1999 and 2003.
|
J Infect Dis
|
2005
|
4.33
|
|
2
|
A phase I clinical trial of a PER.C6 cell grown influenza H7 virus vaccine.
|
Vaccine
|
2009
|
1.80
|
|
3
|
Type I IFN as a natural adjuvant for a protective immune response: lessons from the influenza vaccine model.
|
J Immunol
|
2002
|
1.63
|
|
4
|
Transmission of hemagglutinin D222G mutant strain of pandemic (H1N1) 2009 virus.
|
Emerg Infect Dis
|
2010
|
1.47
|
|
5
|
Interspecies transmission of an H7N3 influenza virus from wild birds to intensively reared domestic poultry in Italy.
|
Virology
|
2004
|
1.47
|
|
6
|
The 1999-2000 avian influenza (H7N1) epidemic in Italy: veterinary and human health implications.
|
Acta Trop
|
2002
|
1.41
|
|
7
|
Molecular characterization of influenza B viruses circulating in northern Italy during the 2001-2002 epidemic season.
|
J Med Virol
|
2003
|
1.27
|
|
8
|
A sensitive one-step real-time PCR for detection of avian influenza viruses using a MGB probe and an internal positive control.
|
BMC Infect Dis
|
2006
|
1.21
|
|
9
|
New insights into the antiviral effects of chloroquine.
|
Lancet Infect Dis
|
2006
|
1.21
|
|
10
|
H3N2 influenza viruses from domestic chickens in Italy: an increasing role for chickens in the ecology of influenza?
|
J Gen Virol
|
2002
|
1.19
|
|
11
|
Evidence of cross-reactive immunity to 2009 pandemic influenza A virus in workers seropositive to swine H1N1 influenza viruses circulating in Italy.
|
PLoS One
|
2013
|
1.17
|
|
12
|
Comparison of in vitro replication features of H7N3 influenza viruses from wild ducks and turkeys: potential implications for interspecies transmission.
|
J Gen Virol
|
2006
|
1.14
|
|
13
|
Generation of candidate human influenza vaccine strains in cell culture - rehearsing the European response to an H7N1 pandemic threat.
|
Influenza Other Respir Viruses
|
2007
|
1.12
|
|
14
|
Human infection with highly pathogenic A(H7N7) avian influenza virus, Italy, 2013.
|
Emerg Infect Dis
|
2014
|
1.09
|
|
15
|
Changes in the hemagglutinins and neuraminidases of human influenza B viruses isolated in Italy during the 2001-02, 2002-03, and 2003-04 seasons.
|
J Med Virol
|
2004
|
1.09
|
|
16
|
Different pH requirements are associated with divergent inhibitory effects of chloroquine on human and avian influenza A viruses.
|
Virol J
|
2007
|
1.06
|
|
17
|
Molecular analysis of avian H7 influenza viruses circulating in Eurasia in 1999-2005: detection of multiple reassortant virus genotypes.
|
J Gen Virol
|
2008
|
1.04
|
|
18
|
Type I IFN is a powerful mucosal adjuvant for a selective intranasal vaccination against influenza virus in mice and affects antigen capture at mucosal level.
|
Vaccine
|
2005
|
1.03
|
|
19
|
Viral causes of influenza-like illness: Insight from a study during the winters 2004-2007.
|
J Med Virol
|
2009
|
1.00
|
|
20
|
New A/H3N2 influenza variant: a small genetic evolution but a heavy burden on the Italian population during the 2004-2005 season.
|
J Clin Microbiol
|
2005
|
0.94
|
|
21
|
Influenza virus circulation in wild aquatic birds in Italy during H5N2 and H7N1 poultry epidemic periods (1998 to 2000).
|
Avian Pathol
|
2005
|
0.94
|
|
22
|
First case in Italy of acquired resistance to oseltamivir in an immunocompromised patient with influenza A/H1N1v infection.
|
J Clin Virol
|
2010
|
0.92
|
|
23
|
Report of two cases of influenza virus A/H1N1v and B co-infection during the 2010/2011 epidemics in the Italian Veneto Region.
|
Virol J
|
2011
|
0.91
|
|
24
|
Type I IFN as a vaccine adjuvant for both systemic and mucosal vaccination against influenza virus.
|
Vaccine
|
2006
|
0.91
|
|
25
|
Understanding the dynamics of seasonal influenza in Italy: incidence, transmissibility and population susceptibility in a 9-year period.
|
Influenza Other Respir Viruses
|
2012
|
0.90
|
|
26
|
Influenza virological surveillance in children: the use of the QuickVue rapid diagnostic test.
|
J Med Virol
|
2004
|
0.89
|
|
27
|
Molecular adaptation of an H7N3 wild duck influenza virus following experimental multiple passages in quail and turkey.
|
Virology
|
2010
|
0.89
|
|
28
|
Can preening contribute to influenza A virus infection in wild waterbirds?
|
PLoS One
|
2010
|
0.88
|
|
29
|
Influenza epidemiology in Italy two years after the 2009-2010 pandemic: need to improve vaccination coverage.
|
Hum Vaccin Immunother
|
2013
|
0.88
|
|
30
|
Cardiac tamponade and heart failure due to myopericarditis as a presentation of infection with the pandemic H1N1 2009 influenza A virus.
|
J Clin Microbiol
|
2010
|
0.87
|
|
31
|
Evaluation of the antiviral drug susceptibility of influenza viruses in Italy from 2004/05 to 2009/10 epidemics and from the recent 2009 pandemic.
|
Antiviral Res
|
2011
|
0.84
|
|
32
|
H5N1 influenza virus evolution: a comparison of different epidemics in birds and humans (1997-2004).
|
J Gen Virol
|
2006
|
0.83
|
|
33
|
Pandemic influenza A/H1N1pdm in Italy: age, risk and population susceptibility.
|
PLoS One
|
2013
|
0.82
|
|
34
|
Estimating pandemic vaccine effectiveness in two Italian regions using the screening method, 2009-2010.
|
Vaccine
|
2011
|
0.81
|
|
35
|
Bovine lactoferrin inhibits influenza A virus induced programmed cell death in vitro.
|
Biometals
|
2010
|
0.81
|
|
36
|
Monitoring the susceptibility to oseltamivir of Influenza A(H1N1) 2009 virus by nested-PCR and pyrosequencing during the pandemic and in the season 2010-2011.
|
J Virol Methods
|
2012
|
0.81
|
|
37
|
Prevalence of antibodies against A and B influenza viruses in South-Western Papua New Guinea.
|
J Med Virol
|
2006
|
0.80
|
|
38
|
Modified vaccinia virus Ankara expressing the hemagglutinin of pandemic (H1N1) 2009 virus induces cross-protective immunity against Eurasian 'avian-like' H1N1 swine viruses in mice.
|
Influenza Other Respir Viruses
|
2013
|
0.80
|
|
39
|
Human monoclonal antibodies in single chain fragment variable format with potent neutralization activity against influenza virus H5N1.
|
Antiviral Res
|
2009
|
0.80
|
|
40
|
Packaging signals in the 5'-ends of influenza virus PA, PB1, and PB2 genes as potential targets to develop nucleic-acid based antiviral molecules.
|
Antiviral Res
|
2011
|
0.79
|
|
41
|
Chlamydophila pneumoniae, Mycoplasma pneumoniae, and influenza in children with respiratory infections in Alexandria, Egypt.
|
J Infect Dev Ctries
|
2014
|
0.78
|
|
42
|
Characterization of human H1N1 influenza virus variants selected in vitro with zanamivir in the presence of sialic acid-containing molecules.
|
Virus Res
|
2007
|
0.78
|
|
43
|
B-sides serologic markers of immunogenicity in kidney transplanted patients: report from 2012-2013 flu vaccination experience.
|
Transplantation
|
2014
|
0.77
|
|
44
|
Reassortment ability of the 2009 pandemic H1N1 influenza virus with circulating human and avian influenza viruses: public health risk implications.
|
Virus Res
|
2013
|
0.76
|
|
45
|
Influenza A(H7N7) Virus among Poultry Workers, Italy, 2013.
|
Emerg Infect Dis
|
2016
|
0.75
|
|
46
|
Evolutionary analysis of HA and NS1 genes of H5N1 influenza viruses in 2004-2005 epidemics.
|
Avian Dis
|
2007
|
0.75
|